- Home
- LDTC vs NVNO Comparison
LDTC vs NVNO Comparison
Compare LDTC & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- NVNO
- Stock Information
- Founded
- LDTC 2007
- NVNO 1987
- Country
- LDTC Canada
- NVNO United States
- Employees
- LDTC N/A
- NVNO N/A
- Industry
- LDTC Blank Checks
- NVNO Medical/Dental Instruments
- Sector
- LDTC Finance
- NVNO Health Care
- Exchange
- LDTC Nasdaq
- NVNO Nasdaq
- Market Cap
- LDTC 37.5M
- NVNO 41.0M
- IPO Year
- LDTC N/A
- NVNO N/A
- Fundamental
- Price
- LDTC $0.43
- NVNO $2.74
- Analyst Decision
- LDTC Buy
- NVNO
- Analyst Count
- LDTC 2
- NVNO 0
- Target Price
- LDTC $3.00
- NVNO N/A
- AVG Volume (30 Days)
- LDTC 168.6K
- NVNO 90.1K
- Earning Date
- LDTC 05-13-2025
- NVNO 05-07-2025
- Dividend Yield
- LDTC N/A
- NVNO N/A
- EPS Growth
- LDTC N/A
- NVNO N/A
- EPS
- LDTC N/A
- NVNO N/A
- Revenue
- LDTC $331,997.00
- NVNO N/A
- Revenue This Year
- LDTC $906.25
- NVNO N/A
- Revenue Next Year
- LDTC $149.88
- NVNO $409.09
- P/E Ratio
- LDTC N/A
- NVNO N/A
- Revenue Growth
- LDTC 141.86
- NVNO N/A
- 52 Week Low
- LDTC $0.22
- NVNO $2.03
- 52 Week High
- LDTC $2.75
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- LDTC 46.01
- NVNO 56.49
- Support Level
- LDTC $0.36
- NVNO $2.61
- Resistance Level
- LDTC $0.42
- NVNO $2.79
- Average True Range (ATR)
- LDTC 0.07
- NVNO 0.19
- MACD
- LDTC 0.01
- NVNO 0.08
- Stochastic Oscillator
- LDTC 37.34
- NVNO 92.78
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.